Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

Raj, N; Chan, JA; Wang, SJ; Aggarwal, RR; Calabrese, S; DeMore, A; Fong, L; Grabowsky, J; Hope, TA; Kolli, KP; Mulvey, CK; Munster, PN; Perez, K; Punn, S; Reidy-Lagunes, D; Von Fedak, S; Zhang, L; Bergsland, EK

Raj, N (通讯作者)，Mem Sloan Kettering MSK Canc Ctr, New York, NY 10065 USA.;Bergsland, EK (通讯作者)，Univ Calif San Francisco UCSF, San Francisco, CA 94115 USA.

BRITISH JOURNAL OF CANCER, 2023; 129 (2): 291

Abstract

BackgroundTo date, single-agent immune checkpoint inhibitor (CPI) therapy has proven to be ineffective against biomarker-unselected extrapulmonary poo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索